These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7335171)

  • 1. [Platelet anti-aggregating therapy with dipyridamole in the prevention of early post-infarct angina].
    Pavia M; Idone P; Ravera A; Rey L; Trucco G; Aquaro G
    Minerva Cardioangiol; 1981 Dec; 29(12):729-33. PubMed ID: 7335171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic results of intravenous perfusion of Persantin in myocardial infarct and severe angina pectoris: 30 cases].
    Pauchant M; Bernard JM
    Lille Med; 1969 Mar; ():Suppl 2:216+. PubMed ID: 5402235
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-platelet-aggregating action of dipyridamole administered by slow intravenous infusion].
    Francini D; Abbate R
    Clin Ter; 1980 Mar; 92(5):477-89. PubMed ID: 7449325
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dipyridamole therapy in acute myocardial infarct].
    Avdiushko BR
    Vrach Delo; 1977 Jan; (1):38-43. PubMed ID: 841989
    [No Abstract]   [Full Text] [Related]  

  • 5. On the factors which affect the immediate and long-term prognosis of myocardial infarction.
    Itatsu H
    Jpn Circ J; 1967 Nov; 31(11):1600-2. PubMed ID: 5630881
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of persantin on selected platelet functions in myocardial infarct].
    Markiewicz M; Kowalewski J; Florkiewicz H; Pluta A; Koziara Z; Szponar M; Dmosyńska A
    Pol Tyg Lek; 1980 Sep; 35(35):1343-5. PubMed ID: 7433215
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative statistical study of the treatment of myocardial infarct with anticoagulants and anti-aggregants].
    Melloni GF; Lureti GF; Minoja GM; Melloni CF; Scarlatti GF; Facchetti M; Fassini G
    Boll Soc Ital Cardiol; 1977; 22(7):1017-26. PubMed ID: 87208
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiaggregant effect of slow-release dipyridamole in acute myocardial infarct].
    Scabbia E; Bellocci F; Montenero AS; Albanese S; Coppola E; Cudillo L
    Minerva Cardioangiol; 1988; 36(7-8):347-50. PubMed ID: 2974931
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anomalies of platelet behavior at the time of myocardial infarct].
    Bouvier CA; Rosner P; Berthoud S; Ritschard J; Scherrer JR; Hausser E
    Cardiologia (Basel); 1967; 50(4):232-8. PubMed ID: 5589124
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
    Diener HC; Darius H; Bertrand-Hardy JM; Humphreys M;
    Int J Clin Pract; 2001 Apr; 55(3):162-3. PubMed ID: 11351768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and electrocardiographical observations on the evolution of myocardial infarct treated with a derivative of pyrimido-pyrimidine (Persantin) in intravenous infusion].
    Martinetti L; Balzano I
    Minerva Med; 1966 Aug; 57(63):2699-710. PubMed ID: 5911867
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations on the treatment of myocardial infarct with 2-6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d)-pyrimidine (Persantin) in slow venous perfusion].
    Marangoni R; Brera V; Ferrari A
    Minerva Cardioangiol; 1966 Jun; 14(6):373-9. PubMed ID: 5917541
    [No Abstract]   [Full Text] [Related]  

  • 13. [Emergency treatment of acute myocardial infarct by means of slow intravenous infusion of a derivative of pyrimido-(5,4-d)-pyrimidine (preparation RA8)].
    Capelli F; Lotto A; Lomanto B
    Minerva Cardioangiol; 1966 Jun; 14(6):367-73. PubMed ID: 5917540
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of dipyridamole (Persantine) in angina pectoris and ischemic heart disease.
    Schwartz WW
    J Am Osteopath Assoc; 1967 Sep; 67(1):68-78. PubMed ID: 5183103
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incidence and intensity of angina pectoris after myocardial infarct].
    Wrabec K; Nowosad H; Parczewska T; Grzelak H
    Pol Tyg Lek; 1980 Dec; 35(50):1945-7. PubMed ID: 7291047
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of bephedon--a new anticoagulant--in myocardial infarct and angina pectoris].
    Semenko IF; Bykov II
    Sov Med; 1969 Jan; 32(1):56-9. PubMed ID: 5385217
    [No Abstract]   [Full Text] [Related]  

  • 17. [The characteristics of postinfarct stenocardia and the recurrence of a myocardial infarct after thrombolytic therapy].
    Chernetsov VA
    Voen Med Zh; 1998 Sep; 319(9):59-63. PubMed ID: 9817019
    [No Abstract]   [Full Text] [Related]  

  • 18. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of angina pectoris and myocardial infarct with etaphene].
    Rubanovskiĭ BR
    Sov Med; 1965 Sep; 28(9):17-21. PubMed ID: 5871691
    [No Abstract]   [Full Text] [Related]  

  • 20. [The persistence of stenocardia in the course of myocardial infarct].
    Lehrer-Grego E; Soldati B; Prevosti L
    Atti Soc Ital Cardiol; 1968; 2():109-11. PubMed ID: 5717483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.